Danish pharmaceutical giant Novo Nordisk is gearing up to launch its innovative weight-loss drug, Ozempic (semaglutide), in India.
This move marks a significant step in addressing obesity and related health issues in the country. Ozempic, known for its efficacy in weight management, has garnered global attention for its potential to improve patients’ quality of life.
With its upcoming launch, Novo Nordisk aims to provide Indian patients access to this groundbreaking treatment, aligning with the growing demand for effective weight-loss solutions.
https://www.newsbytesapp.com/news/science/novo-nordisk-to-soon-launch-weight-loss-drug-ozempic-in-india/story
